Brind.

Zymeworks and Cytokinetics are companies operating in the medical/biomedical sector.

1 report, 1 independent Updated Jul 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Zymeworks Cytokinetics

Keep exploring

The entities involved

Zymeworks
company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01
Cytokinetics
company in South San Francisco, United States
- Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.Sun 00:44
- The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.Wed 15:26

Coverage

Newest first; wire copies grouped

Jul 18ZacksZymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains? Zymeworks Inc. (ZYME) shares soared 7.1% in the last trading session to close at $14.48. The move was backed by solid volume with